Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Protein tyrosine kinase inhibitors for cancer, polycystic kidney disease

Nov. 12, 1998

New anticancer drug candidate revealed by Sugen; product enters phase I testing in U.K.

Nov. 11, 1998

Promising interim results announced for SU-5416 phase I trial

Nov. 10, 1998

Two major clinical studies demonstrate chemo- and radioprotective activity of amifostine

Nov. 10, 1998

Ribozyme initiates phase I clinical trials of Angiozyme

Nov. 9, 1998

GBC-590 effective in murine model of treatment-resistant pancreatic cancer

Nov. 9, 1998

Progen commences phase I trials of PI-88 in the U.K.

Nov. 6, 1998

Phase II trials demonstrate ability of Onco TCS to reduce tumor size in NHL patients

Nov. 6, 1998

Chinese researchers synthesize cytotoxic alkaloid derivative HH-07A

Nov. 6, 1998

Licensing opportunity from the NIH: method of inhibiting HGF/SF cleavage, activation

Nov. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...